CCI vs KURA · P/E 40, rev $2.02B vs rev $20.9M
Crown Castle (CCI) versus Kura Oncology Inc (KURA) — a side-by-side from cached financials, not a winner call.
Crown Castle (CCI) is a reit - specialty company listed on US.
Kura Oncology Inc (KURA) is a biotechnology company listed on NASDAQ.
Latest reported CCI revenue for 2026-06-30 was $2.02B. Net income was $245.0M. Revenue was up 99.8% from 2026-03-31 to 2026-06-30. CCI currently screens at market cap $40.93B and trailing P/E 39.6.
Latest reported KURA revenue for 2026-06-30 was $20.9M. Net income was -$68.3M. Revenue was up 14.3% from 2026-03-31 to 2026-06-30. KURA currently screens at market cap $861.1M.
CCI currently screens at market cap $40.93B and trailing P/E 39.6. KURA currently screens at market cap $861.1M.
Not investment advice. Open the CCI and KURA stock pages for the full models.
Not investment advice.